Loading…
4 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Geo Medi | Pharma | 46.2% | 94th pct | 110 |
| Rustavis Tek. Inspektir… | Auto & Auto Parts | 25.1% | 88th pct | 179 |
| Geo-Airi | (unclassified) | 3.4% | 31st pct | 1208 |
| Progresi | FMCG | 1.3% | 25th pct | 543 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Ratio — FY 2024 | Progresi | Geo Medi | Geo-Airi | Rustavis Tek. Inspektir… |
|---|---|---|---|---|
| Margins | ||||
| Gross Margin | 15.5% | 83.4% | 18.5% | 100.0% |
| EBITDA Margin | 1.3% | 46.2% | 3.4% | 25.1% |
| EBITDAR | 299 | 791 | 48 | 212 |
| EBITDAR Margin | 1.3% | 48.2% | 3.4% | 25.1% |
| EBIT Margin | 1.3% | 44.4% | -0.2% | 17.2% |
| Net Profit Margin | 0.7% | 26.2% | -0.2% | -5.9% |
| Operating Expense % of Sales | 14.2% | 37.2% | 15.0% | 74.9% |
| Returns | ||||
| Return on Assets (ROA) | 2.1% | 54.0% | -0.2% | -0.9% |
| Return on Equity (ROE) | 23.5% | 65.1% | -0.2% | -17.1% |
| ROIC [EBIT / Invested Capital] | 5.5% | 125.3% | -0.2% | 7.2% |
| Leverage & debt balances | ||||
| Debt-to-Assets | 63.7% | 0.0% | 0.0% | 39.8% |
| Debt-to-Equity | 7.25x | 0.00x | 0.00x | 7.22x |
| Debt-to-EBITDA | 16.61x | 0.00x | 0.00x | 9.86x |
| Equity-to-Assets | 8.8% | 83.0% | 81.0% | 5.5% |
| Net Debt | 4,723 | -78 | -0 | 1,743 |
| Cash & Equivalents | 241 | 78 | 0 | 351 |
| Total Debt | 4,965 | N/A | N/A | 2,093 |
| Liquidity & working capital | ||||
| Current Ratio | 1.34x | 4.57x | 0.56x | 19.96x |
| Quick Ratio | 0.58x | 4.57x | 0.56x | 19.96x |
| Cash Ratio | 0.08x | 0.58x | 0.00x | 1.87x |
| Total Current Assets | 4,235 | 618 | 128 | 3,743 |
| Total Current Liabilities | 3,172 | 135 | 227 | 188 |
| Inventory | 2,405 | N/A | N/A | N/A |
| Trade Receivables | 1,588 | 514 | 122 | 307 |
| Trade Payables | 1,526 | 134 | 227 | 188 |
| Net Working Capital | 1,063 | 483 | -99 | 3,556 |
| Net Working Capital % of Revenue | 4.5% | 29.4% | -7.0% | 420.2% |
| Trade Working Capital | 2,467 | 380 | -106 | 119 |
| Trade Working Capital % of Revenue | 10.4% | 23.1% | -7.4% | 14.1% |
| Change in Trade Working Capital | N/A | N/A | N/A | N/A |
| Turnover & efficiency | ||||
| Inventory Turnover | 8.31x | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | 43.9 | N/A | N/A | N/A |
| Receivables Turnover | 14.89x | 3.19x | 11.66x | 2.76x |
| Days Sales Outstanding (DSO) | 24.5 | 114.3 | 31.3 | 132.4 |
| Payables Turnover | 13.09x | 2.03x | 5.09x | N/A |
| Days Payable Outstanding (DPO) | 27.9 | 180.2 | 71.7 | N/A |
| Cash Conversion Cycle | 40.6 days | -65.9 days | -40.4 days | 132.4 days |
| Asset Turnover | 3.03x | 2.06x | 1.18x | 0.16x |
| Cash flow & dividends | ||||
| Operating Cash Flow | 347 | -155 | -4 | 258 |
| Free Cash Flow (OCF − Capex proxy) | 300 | -155 | -4 | 258 |
| Cash Conversion (OCF / EBITDA) | 116.2% | -20.4% | -7.3% | 121.5% |
| Dividends Declared | 0 | N/A | N/A | N/A |
| Dividend Payout Ratio | 0.0% | N/A | N/A | N/A |